Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors
Cathryn Weston, Ian J. Winfield, Matthew Harris, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 42, pp. 21925-21944
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Debbie L. Hay, Michael L. Garelja, David R. Poyner, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 1, pp. 3-17
Open Access | Times Cited: 333
Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor
Yi-Lynn Liang, Maryam Khoshouei, Giuseppe Deganutti, et al.
Nature (2018) Vol. 561, Iss. 7724, pp. 492-497
Open Access | Times Cited: 233
The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects
Zizheng Kee, Xenia Kodji, Susan D. Brain
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 165
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Andrew F. Russo, Debbie L. Hay
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1565-1644
Open Access | Times Cited: 162
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
Adisa Kuburas, Andrew F. Russo
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 49
Don’t stress about CRF: assessing the translational failures of CRF1antagonists
Samantha R. Spierling, Eric P. Zorrilla
Psychopharmacology (2017) Vol. 234, Iss. 9-10, pp. 1467-1481
Open Access | Times Cited: 156
The Activity of Peptides of the Calcitonin Family in Bone
Dorit Naot, David S. Musson, Jillian Cornish
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 781-805
Open Access | Times Cited: 118
Combinatorial expression of GPCR isoforms affects signalling and drug responses
Maria Martí-Solano, Stephanie E. Crilly, Duccio Malinverni, et al.
Nature (2020) Vol. 587, Iss. 7835, pp. 650-656
Open Access | Times Cited: 115
Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins
Yi-Lynn Liang, Matthew J. Belousoff, Madeleine M. Fletcher, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 2, pp. 263-284
Open Access | Times Cited: 87
Migraine therapeutics differentially modulate the CGRP pathway
Minoti Bhakta, Trang Vuong, Tetsuya Taura, et al.
Cephalalgia (2021) Vol. 41, Iss. 5, pp. 499-514
Open Access | Times Cited: 80
Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression
Mark J. Wall, Emily Hill, Robert Huckstepp, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Research Progress in Calcitonin Gene-Related Peptide and Bone Repair
Qichang Wang, Haotian Qin, Jiapeng Deng, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 838-838
Open Access | Times Cited: 23
Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family
Michael J. Woolley, Alex C. Conner
Molecular and Cellular Endocrinology (2016) Vol. 449, pp. 3-11
Open Access | Times Cited: 75
Sex differences in the hypothalamic–pituitary–adrenal axis: An obstacle to antidepressant drug development?
Nikolaos Kokras, Georgia E. Hodes, Debra A. Bangasser, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 21, pp. 4090-4106
Open Access | Times Cited: 74
Adrenomedullin – new perspectives of a potent peptide hormone
Ria Schönauer, Sylvia Els‐Heindl, Annette G. Beck‐Sickinger
Journal of Peptide Science (2017) Vol. 23, Iss. 7-8, pp. 472-485
Closed Access | Times Cited: 71
Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin
Rebekah L. Bower, Lauren R. Yule, Tayla A. Rees, et al.
ACS Pharmacology & Translational Science (2018) Vol. 1, Iss. 1, pp. 32-49
Open Access | Times Cited: 65
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Jingbo Xie, Jian Guo, Zaeema Kanwal, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-20
Open Access | Times Cited: 53
Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System
László Bálint, Nathan Nelson-Maney, Yanna Tian, et al.
Circulation Research (2023) Vol. 132, Iss. 9, pp. 1185-1202
Closed Access | Times Cited: 21
Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases
Song‐Yang Zhang, Mingjiang Xu, Xian Wang
British Journal of Pharmacology (2017) Vol. 175, Iss. 8, pp. 1230-1240
Open Access | Times Cited: 59
Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors
Wessel A. C. Burger, Patrick M. Sexton, Arthur Christopoulos, et al.
The Journal of General Physiology (2018) Vol. 150, Iss. 10, pp. 1360-1372
Open Access | Times Cited: 50
The GPCR accessory protein MRAP2 regulates both biased signaling and constitutive activity of the ghrelin receptor GHSR1a
Alix A.J. Rouault, Luciana K. Rosselli‐Murai, Ciria C. Hernández, et al.
Science Signaling (2020) Vol. 13, Iss. 613
Open Access | Times Cited: 46
RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors
Augen A. Pioszak, Debbie L. Hay
Advances in pharmacology (2020), pp. 115-141
Open Access | Times Cited: 40
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
Ilana B. Kotliar, Emily Lorenzen, Jochen M. Schwenk, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 1-34
Open Access | Times Cited: 28
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists
Peter Keov, George Christopoulos, Caroline A. Hick, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 5, pp. 359-373
Open Access | Times Cited: 5
Variable CGRP family peptide signaling durations and the structural determinants thereof
Katie M. Babin, Sandra E. Gostynska, Jordan A Karim, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116235-116235
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top